Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-26-012672
Filing Date
2026-03-25
Accepted
2026-03-25 16:13:15
Documents
76
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K form10-k.htm   iXBRL 10-K 1758666
2 EX-23.1 ex23-1.htm EX-23.1 5144
3 EX-31.1 ex31-1.htm EX-31.1 21220
4 EX-31.2 ex31-2.htm EX-31.2 21120
5 EX-32.1 ex32-1.htm EX-32.1 7988
6 EX-32.2 ex32-2.htm EX-32.2 8130
7 GRAPHIC form10-k_001.jpg GRAPHIC 8531
  Complete submission text file 0001493152-26-012672.txt   8627120

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE dyai-20251231.xsd EX-101.SCH 50967
9 XBRL CALCULATION FILE dyai-20251231_cal.xml EX-101.CAL 73002
10 XBRL DEFINITION FILE dyai-20251231_def.xml EX-101.DEF 293983
11 XBRL LABEL FILE dyai-20251231_lab.xml EX-101.LAB 532861
12 XBRL PRESENTATION FILE dyai-20251231_pre.xml EX-101.PRE 444312
79 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1313576
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32513 | Film No.: 26792581
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)